AMG.DE vs. ABBV
Compare and contrast key facts about Amgen Inc (AMG.DE) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMG.DE or ABBV.
Correlation
The correlation between AMG.DE and ABBV is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMG.DE vs. ABBV - Performance Comparison
Key characteristics
AMG.DE:
-0.43
ABBV:
0.73
AMG.DE:
-0.49
ABBV:
0.99
AMG.DE:
0.93
ABBV:
1.15
AMG.DE:
-0.64
ABBV:
0.88
AMG.DE:
-1.42
ABBV:
2.15
AMG.DE:
9.67%
ABBV:
8.44%
AMG.DE:
27.69%
ABBV:
27.49%
AMG.DE:
-70.17%
ABBV:
-45.09%
AMG.DE:
-21.27%
ABBV:
-13.55%
Fundamentals
AMG.DE:
€134.44B
ABBV:
$351.09B
AMG.DE:
€9.72
ABBV:
$2.34
AMG.DE:
25.24
ABBV:
84.82
AMG.DE:
0.93
ABBV:
0.42
AMG.DE:
3.94
ABBV:
6.05
AMG.DE:
23.91
ABBV:
105.59
AMG.DE:
€34.13B
ABBV:
$57.37B
AMG.DE:
€21.50B
ABBV:
$44.44B
AMG.DE:
€11.52B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, AMG.DE achieves a -3.03% return, which is significantly lower than ABBV's 6.39% return. Over the past 10 years, AMG.DE has underperformed ABBV with an annualized return of 8.43%, while ABBV has yielded a comparatively higher 15.79% annualized return.
AMG.DE
-3.03%
-9.81%
-17.71%
-11.83%
5.60%
8.43%
ABBV
6.39%
6.62%
-5.71%
19.87%
22.17%
15.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMG.DE vs. ABBV — Risk-Adjusted Performance Rank
AMG.DE
ABBV
AMG.DE vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amgen Inc (AMG.DE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMG.DE vs. ABBV - Dividend Comparison
AMG.DE's dividend yield for the trailing twelve months is around 3.14%, less than ABBV's 3.44% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMG.DE Amgen Inc | 3.14% | 2.95% | 2.69% | 2.65% | 2.63% | 2.72% | 2.15% | 2.41% | 2.47% | 2.28% | 1.68% | 1.22% |
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
AMG.DE vs. ABBV - Drawdown Comparison
The maximum AMG.DE drawdown since its inception was -70.17%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AMG.DE and ABBV. For additional features, visit the drawdowns tool.
Volatility
AMG.DE vs. ABBV - Volatility Comparison
Amgen Inc (AMG.DE) has a higher volatility of 11.73% compared to AbbVie Inc. (ABBV) at 10.10%. This indicates that AMG.DE's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMG.DE vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Amgen Inc and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMG.DE vs. ABBV - Profitability Comparison
AMG.DE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amgen Inc reported a gross profit of 5.18B and revenue of 8.15B. Therefore, the gross margin over that period was 63.6%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
AMG.DE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amgen Inc reported an operating income of 1.18B and revenue of 8.15B, resulting in an operating margin of 14.5%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
AMG.DE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amgen Inc reported a net income of 1.73B and revenue of 8.15B, resulting in a net margin of 21.2%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.